eLetters

243 e-Letters

published between 2003 and 2006

  • National Patient Safety Agency Protocol for Pre-operative Site Marking
    Philip Alexander

    Sir

    Fraser and Adams's commentary suggests that the most important method of reducing wrong site surgery is to have a consistent and robust protocol (1). They also give examples of numerous factors that disrupt the smooth running of the system and increase potential for harm. In March 2005, the National Patient Safety Agency produced a Patient Safety Alert in an attempt to standardise preoperative marking an...

    Show More
  • Eye growth and refraction in preterms with and without retinal ablation therapy for ROP
    Hans C Fledelius

    Dear Editor,

    I can join the editorial appreciation of Axer-Siegel and coworker's recent article,1 as expressed by O'Keefe and Kirwan.2 In an experimental set-up the authors studied the effects of cryo- vs. diode laser application on the axial eye growth in 6-week-old rabbits. The induced eye wall trauma stimulated growth, of both anterior and posterior eye segment. This can be compared to the axial elongation...

    Show More
  • IVTA and glaucoma: Brazil report
    Daniel Vítor Vasconcelos-Santos

    Dear Editor,

    We read with interest Rhee and co-workers' paper on intra-ocular pressure (IOP) alterations following intravitreal triamcinolone acetonide (IVTA) injection.[1] They presented the largest published patient series with the 4mg dose of IVTA (570 eyes of 536 patients). Furthermore, their comprehensive analysis concerning multiple criteria of IOP elevation (>5mmHg, >10mmHg and 30% increase from th...

    Show More
  • Patient safety and ophthalmic surgery marking - which side are you on?
    Mary Milner White

    Dear Editor,

    We read with interest the paper by Fraser and Adams[1], which suggested many reasons for the wrong site surgery and also suggested ways of preventing it. We carried out semi-structured interviews of ophthalmic surgeons (Consultants and Specialist registrar) throughout Scotland by telephone on their current practices and attitudes relating to preventing wrong side surgery in ophthalmology and describe...

    Show More
  • Blue light and Stargardt disease
    Robert M. Hammer

    Dear Editor,

    I enjoyed reading Paskowitz et al.'s (1) important summary of evidence indicating that in some specific types of retinal degeneration, light deprivation may prove to be of protective value. In respect of Stargardt Disease, they cite evidence from animal models that light deprivation can prevent A2E accumulation in the RPE, thus preventing the degeneration. A worthwhile point to note is that the dest...

    Show More
  • Author's Response
    Anne E Fung

    Dear Editor:

    With great interest, we read the comments of Dr. Ziemssen and colleagues regarding our World View paper discussing the results of the international intravitreal bevacizumab safety survey[1]. Their letter will certainly accentuate the importance of this topic to the ophthalmic community; we would like to clarify several of the points raised.

    In our paper, we have fully acknowledged the pur...

    Show More
  • The international intravitreal bevacizumab safety survey
    Focke Ziemssen

    Dear Editor,

    We read with interest the article by Fung et al. assessing complications related to single or repeated intravitreal injections of bevacizumab. [1] We congratulate the authors on studying this innovative therapy via internet and greatly appreciate the effort to gather timely information about the potentially related adverse events. Using a product for an indication not in the approved labeling, the ph...

    Show More
  • Glaucoma screening and optometric services
    Reshma S Thampy

    Dear Editor,

    Stoutenbeek and Jansonius have demonstrated high rates of optometric consultations in the Netherlands as a basis for screening populations at risk of glaucoma .One of the aims of screening is understood to be the early detection of morbidity. We recently published a review[1] of all glaucoma patients registered blind at Manchester Royal Eye Hospital in 2003 and found that only 42% of these had their...

    Show More
  • Giant retinal tear associated with gas tamponade
    Sujith Vengayil*

    Dear Editor,

    We read with great interest the scientific report published in your journal by Zaidi AA et al(1) regarding their experience with pneumatic retinopexy. We express our willingness to share our experience with a unique complication mentioned by the authors. Giant retinal tear was observed in one patient in the study by the author, which required scleral buckle with vitrectomy.

    A 32-year-old m...

    Show More
  • Persistent localised subretinal fluid after scleral buckling with silicone oil tamponade
    Veerappan R Saravanan

    Dear Editor,

    We read with keen interest the article by Atmaca-Sonmez et al on "Persistent detachment of the fovea after non-buckling repair of rhegmatogenous retinal detachment".[1] As stated in the article the presence of persistent detachment of the fovea and localised delayed subretinal fluid absorption (DSRFA) has been noted quite frequently after scleral buckling and pneumatic retinopexy, after the advent of...

    Show More

Pages